Heat shock proteins and cardiovascular disease

Advances in Clinical Chemistry

Volumn 64, Issue , 2014, Pages 73-115

  Zilaee, Marzie ^a   Ferns, Gordon A A ^b   Ghayour Mobarhan, Majid ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Cardiovascular disease; Heat shock proteins; Infection; Inflammation

Indexed keywords

HEAT SHOCK PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; CARDIOMEGALY; CARDIOVASCULAR DISEASES; HEART FAILURE; HUMAN; MOLECULAR MIMICRY; MYOCARDIAL ISCHEMIA; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; CARDIOMEGALY; CARDIOVASCULAR DISEASES; HEART FAILURE; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR MIMICRY; MYOCARDIAL ISCHEMIA;

EID: 84897930939     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800263-6.00002-1     Document Type: Chapter

References (243)

1. Chen Y., Voegeli T.S., Liu P.P., Noble E.G., Currie R.W. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm. Allergy Drug Targets 2007, 6(2):91-100.
2. Riganò R., Profumo E., Buttari B., Tagliani A., Petrone L., D'Amati G., et al. Heat shock proteins and autoimmunity in patients with carotid atherosclerosis. Ann. N. Y. Acad. Sci. 2007, 1107(1):1-10.
3. Madrigal-Matute J., Martin-Ventura J.L., Blanco-Colio L.M., Egido J., Michel J.-B., Meilhac O. Heat-shock proteins in cardiovascular disease. Adv. Clin. Chem. 2011, 54:1-43.
4. Currie R.W., Karmazyn M., Kloc M., Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ. Res. 1988, 63(3):543-549.
5. Williams R.A. Cardiovascular disease in African American women: a health care disparities issue. J. Natl. Med. Assoc. 2009, 101(6):536-540.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801.
7. Donders H., de Lange J. The association between periodontitis and atherosclerosis: the current state of knowledge. J. Cranio-Maxillary Dis. 2012, 1(1):17.
8. Arrigo A., Welch W. Characterization and purification of the small 28,000-dalton mammalian heat shock protein. J. Biol. Chem. 1987, 262(32):15359-15369.
9. Ferns G.A.A. Multiple step-variable pathway hypothesis: a reason why predictions fail in atherosclerosis. Med. Hypotheses 2008, 71(6):923-926.
10. Profumo E., Buttari B., Saso L., Capoano R., Salvati B., Riganò R. T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosis. Scientific World Journal 2012, 2012.
11. Ghayour-Mobarhan M., Rahsepar A., Tavallaie S., Rahsepar S., Ferns G. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv. Clin. Chem. 2009, 48:27-72.
12. Lenzi C., Palazzuoli A., Giordano N., Alegente G., Gonnelli C., Campagna M.S., et al. H. pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J. Gastroenterol. 2006, 12(48):7815.
13. Xu Q., Oberhuber G., Gruschwitz M., Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 1990, 56(3):344-359.
14. Libby P. Biology of disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 1991, 64:5-15.
15. Napoli C., D'Armiento F., Mancini F., Postiglione A., Witztum J., Palumbo G., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Investig. 1997, 100(11):2680.
16. Millonig G., Niederegger H., Rabl W., Hochleitner B., Hoefer D., Romani N., et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler. Thromb. Vasc. Biol. 2001, 21(4):503-508.
17. Kleindienst R., Xu Q., Willeit J., Waldenberger F., Weimann S., Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am. J. Pathol. 1993, 142(6):1927.
18. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001, 21(12):1876-1890.
19. Millonig G., Malcom G.T., Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002, 160(2):441-448.
20. Metzler B., Mayr M., Dietrich H., Singh M., Wiebe E., Xu Q., et al. Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 1999, 19(8):1905-1911.
21. Grayston J.T., Kronmal R.A., Jackson L.A., Parisi A.F., Muhlestein J.B., Cohen J.D., et al. Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 2005, 352(16):1637-1645.
22. Van der Wal A., Das P., Bentz B.D., Van der Loos C., Becker A. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab. Invest. 1989, 61(2):166.
23. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis. JAMA 2001, 285(19):2481-2485.
24. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002, 347(20):1557-1565.
25. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103(8):1064-1070.
26. Yu H., Rifai N. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin. Biochem. 2000, 33(8):601.
27. Poston R., Haskard D., Coucher J., Gall N., Johnson-Tidey R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 1992, 140(3):665.
28. Torzewski J., Bowyer D.E., Waltenberger J., Fitzsimmons C. Processes in atherogenesis: complement activation. Atherosclerosis 1997, 132(2):131-138.
29. Prohászka Z., Duba J., Lakos G., Kiss E., Varga L., Jánoskuti L., et al. Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int. Immunol. 1999, 11(9):1363-1370.
30. de Villiers W.J., Smith J.D., Miyata M., Dansky H.M., Darley E., Gordon S. Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (Op) and apolipoprotein E. Arterioscler. Thromb. Vasc. Biol. 1998, 18(4):631-640.
31. Rajavashisth T., Qiao J.-H., Tripathi S., Tripathi J., Mishra N., Hua M., et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Investig. 1998, 101(12):2702.
32. Mallat Z., Ait-Oufella H., Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc. Med. 2007, 17(4):113-118.
33. Szodoray P., Timar O., Veres K., Der H., Szomjak E., Lakos G., et al. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand. J. Immunol. 2006, 64(3):336-344.
34. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003, 107(16):2109-2114.
35. Elkind M.S., Rundek T., Sciacca R.R., Ramas R., Chen H.J., Boden-Albala B., et al. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis 2005, 180(1):181-187. Epub 2005/04/13.
36. Okazaki S., Furukado S., Abe Y., Tanaka M., Miwa K., Yamagami H., et al. Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients. Cerebrovasc. Dis. 2010, 30(2):180-187. Epub 2010/07/01.
37. Epstein S.E., Zhu J., Najafi A.H., Burnett M.S. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 2009, 119(24):3133-3141.
38. Burnett M.S., Gaydos C.A., Madico G.E., Glad S.M., Paigen B., Quinn T.C., et al. Atherosclerosis in apoE knockout mice infected with multiple pathogens. J. Infect. Dis. 2001, 183(2):226-231.
39. Li L., Messas E., Batista E.L., Levine R.A., Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002, 105(7):861-867.
40. Caligiuri G., Rottenberg M., Nicoletti A., Wigzell H., Hansson G.K. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 2001, 103(23):2834-2838.
41. Ishihara K., Nabuchi A., Ito R., Miyachi K., Kuramitsu H.K., Okuda K. Correlation between detection rates of periodontopathic bacterial DNA in coronary stenotic artery plaque and in dental plaque samples. J. Clin. Microbiol. 2004, 42(11):5437.
42. Kuo C.-C., Grayston J.T., Patton D.L., Fukushi H., Campbell L.A., Shor A. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 1993, 167(4):841-849.
43. Chiu B., Viira E., Tucker W., Fong I. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997, 96(7):2144-2148.
44. Kalayoglu M.V., Libby P., Byrne G.I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002, 288(21):2724-2731.
45. O'Connor C.M., Dunne M.W., Pfeffer M.A., Muhlestein J.B., Yao L., Gupta S., et al. Azithromycin for the secondary prevention of coronary heart disease events. JAMA 2003, 290(11):1459-1466.
46. Cercek B., Shah P.K., Noc M., Zahger D., Zeymer U., Matetzky S., et al. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003, 361(9360):809-813.
47. Xiao Q., Mandal K., Schett G., Mayr M., Wick G., Oberhollenzer F., et al. Association of serum-soluble heat shock protein 60 with carotid atherosclerosis clinical significance determined in a follow-up study. Stroke 2005, 36(12):2571-2576.
48. Prelipcean C.C., Mihai C., Gogǎlniceanu P., Mitricǎ D., Drug V., Stanciu C. Extragastric manifestations of Helicobacter pylori infection. Rev. Med.Chir. Soc. Med. Nat. Iaşi 2007, 111(3):575.
49. Majka J., Róg T., Konturek P.C., Konturek S.J., Bielański W., Kowalsky M., et al. Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors. Med. Sci. Monit. 2002, 8(10):CR675.
50. Yusuf S.W., Mishra R.M. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol. 2002, 57(5):317.
51. Pedicino D., Giglio A.F., Galiffa V.A., Cialdella P., Trotta F., Graziani F., et al. Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions. Int. J. Cardiol. 2012, 3:572-583.
52. Pesonen E., Paakkari I., Rapola J. Infection-associated intimal thickening in the coronary arteries of children. Atherosclerosis 1999, 142(2):425.
53. Chmiela M., Kowalewicz-Kulbat M., Miszczak A., Wisniewska M., Rechcinski T., Kolodziej K., et al. A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immunol. Med. Microbiol. 2006, 36(3):187-192.
54. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Rippin G., et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002, 105(1):15-21.
55. Rosenfeld M.E. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr. Opin. Pharmacol. 2013, 3:154-160. Epub 2013/01/30.
56. Ohashi R., Mu H., Yao Q., Chen C. Atherosclerosis: immunopathogenesis and immunotherapy. Med. Sci. Monit. 2004, 10(11):RA255.
57. Åkerfelt M., Morimoto R.I., Sistonen L. Heat shock factors: integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 2010, 11(8):545-555.
58. Ritossa F. A new puffing pattern induced by temperature shock and DNP in Drosophila. Cell. Mol. Life Sci. 1962, 18(12):571-573.
59. Xu Q., Metzler B., Jahangiri M., Mandal K. Molecular chaperones and heat shock proteins in atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 2012, 302(3):H506-H514.
60. Ranford J., Henderson B. Chaperonins in disease: mechanisms, models, and treatments. Mol. Pathol. 2002, 55(4):209-213.
61. Ghayour-Mobarhan M., Saber H., Ferns G.A. The potential role of heat shock protein 27 in cardiovascular disease. Clin. Chim. Acta 2012, 413(1):15-24.
62. Lindquist S., Craig E. The heat-shock proteins. Annu. Rev. Genet. 1988, 22(1):631-677.
63. Parcellier A., Gurbuxani S., Schmitt E., Solary E., Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem. Biophys. Res. Commun. 2003, 304(3):505-512.
64. Mounier N., Arrigo A.P. Actin cytoskeleton and small heat shock proteins: how do they interact?. Cell Stress Chaperones 2002, 7(2):167.
65. Waters E.R., Lee G.J., Vierling E. Evolution, structure and function of the small heat shock proteins in plants. J. Exp. Bot. 1996, 47(3):325-338.
66. Boston R.S., Viitanen P.V., Vierling E. Molecular chaperones and protein folding in plants. Plant Mol. Biol. 1996, 32(1):191-222.
67. Mattila K.J., Nieminen M.S., Valtonen V.V., Rasi V.P., Kesäniemi Y.A., Syrjälä S.L., et al. Association between dental health and acute myocardial infarction. BMJ 1989, 298(6676):779.
68. Badrichani A., Stroka D., Bilbao G., Curiel D., Bach F., Ferran C. Bcl-2 and Bcl-X L serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J. Clin. Investig. 1999, 103:543-553.
69. Kato K., Goto S., Inaguma Y., Hasegawa K., Morishita R., Asano T. Purification and characterization of a 20-kDa protein that is highly homologous to alpha B crystallin. J. Biol. Chem. 1994, 269(21):15302-15309.
70. Benjamin I.J., McMillan D.R. Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease. Circ. Res. 1998, 83(2):117-132.
71. Kozawa O., Matsuno H., Niwa M., Hatakeyama D., Oiso Y., Kato K., et al. HSP20, low-molecular-weight heat shock-related protein, acts extracellularly as a regulator of platelet functions: a novel defense mechanism. Life Sci. 2002, 72(2):113-124.
72. Lu X., Kakkar V. The role of heat shock protein (HSP) in atherosclerosis: pathophysiology and clinical opportunities. Curr. Med. Chem. 2010, 17(10):957-973.
73. Latchman D.S. Heat shock proteins and cardiac protection. Cardiovasc. Res. 2001, 51(4):637-646.
74. Martin-Ventura J.L., Nicolas V., Houard X., Blanco-Colio L.M., Leclercq A., Egido J., et al. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26(6):1337-1343.
75. Santell L., Bartfeld N.S., Levin E.G. Identification of a protein transiently phosphorylated by activators of endothelial cell function as the heat-shock protein HSP27. A possible role for protein kinase C. Biochem. J. 1992, 284(Pt. 3):705.
76. Martin J., Hickey E., Weber L., Dillmann W., Mestril R. Influence of phosphorylation and oligomerization on the protective role of the small heat shock protein 27 in rat adult cardiomyocytes. Gene Expr. 1999, 7(4-6):349.
77. De A.K., Kodys K.M., Yeh B.S., Miller-Graziano C. Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus. J. Immunol. 2000, 165(7):3951-3958. Epub 2000/10/18.
78. Salinthone S., Tyagi M., Gerthoffer W.T. Small heat shock proteins in smooth muscle. Pharmacol. Ther. 2008, 119(1):44-54.
79. Dybdahl B., Slørdahl S., Waage A., Kierulf P., Espevik T., Sundan A. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 2005, 91(3):299-304.
80. Shams S., Shafi S., Bodman-Smith K., Williams P., Mehta S., Ferns G.A. Anti-heat shock protein-27 (Hsp-27) antibody levels in patients with chest pain: association with established cardiovascular risk factors. Clin. Chim. Acta 2008, 395(1):42-46.
81. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2002, 22(10):1547-1559.
82. Chandra D., Choy G., Tang D.G. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J. Biol. Chem. 2007, 282(43):31289-31301.
83. Kim S.-C., Stice J.P., Chen L., Jung J.S., Gupta S., Wang Y., et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ. Res. 2009, 105(12):1186-1195.
84. Deocaris C.C., Kaul S.C., Wadhwa R. On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60. Cell Stress Chaperones 2006, 11(2):116.
85. Sigal L.H., Williams S., Soltys B., Gupta R. H9724, a monoclonal antibody to Borrelia burgdorferi's flagellin, binds to heat shock protein 60 (HSP60) within live neuroblastoma cells: a potential role for HSP60 in peptide hormone signaling and in an autoimmune pathogenesis of the neuropathy of Lyme disease. Cell. Mol. Neurobiol. 2001, 21(5):477-495.
86. Erkkilä L., Laitinen K., Haasio K., Tiirola T., Jauhiainen M., Lehr H.A., et al. Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection. Atherosclerosis 2004, 177(2):321-328.
87. Pockley A.G., Wu R., Lemne C., Kiessling R., de Faire U., Frostegård J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 2000, 36(2):303-307.
88. Mandal K., Afzal A., Brecker S., Poloniecki J., Xu Q., Jahangiri M. Association of serum soluble heat shock protein 60 with toll-like receptor 4 polymorphism and severity of coronary artery disease. Heart 2006, 92(5):683-685.
89. Zhu J., Quyyumi A.A., Rott D., Csako G., Wu H., Halcox J., et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001, 103(8):1071-1075.
90. Hoppichler F., Lechleitner M., Traweger C., Schett G., Dzien A., Sturm W., et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996, 126(2):333-338.
91. Veres A., Heart Outcomes Prevention Evaluation (HOPE) Study Investigators Relationship of anti-60kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation 2002, 106:2775.
92. Madrigal-Matute J., López-Franco O., Blanco-Colio L.M., Muñoz-García B., Ramos-Mozo P., Ortega L., et al. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc. Res. 2010, 86(2):330-337.
93. Morris S.D., Cumming D., Latchman D.S., Yellon D.M. Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression?. J. Clin. Investig. 1996, 97(3):706.
94. Johnson A.D., Berberian P.A., Tytell M., Bond M.G. Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival. Arterioscler. Thromb. Vasc. Biol. 1995, 15(1):27-36.
95. Pockley A.G., Georgiades A., Thulin T., de Faire U., Frostegård J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003, 42(3):235-238.
96. Martin-Ventura J.L., Leclercq A., Blanco-Colio L.M., Egido J., Rossignol P., Meilhac O., et al. Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 2007, 194(2):334-341.
97. Herz I., Rosso R., Roth A., Keren G., George J. Serum levels of anti heat shock protein 70 antibodies in patients with stable and unstable angina pectoris. Acute Card. Care 2006, 8(1):46-50.
98. Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999, 100(11):1169-1174.
99. Lin L.-Y., Lin C.-Y., Su T.-C., Liau C.-S. Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett. 2004, 574(1):106-110.
100. Shi Y., Mosser D.D., Morimoto R.I. Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev. 1998, 12(5):654-666.
101. Businaro R., Profumo E., Tagliani A., Buttari B., Leone S., D'Amati G., et al. Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 2009, 207(1):74-83.
102. Wick G., Knoflach M., Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 2004, 22:361-403.
103. Van Eden W., Wick G., Albani S., Cohen I. Stress, heat shock proteins, and autoimmunity. Ann. N. Y. Acad. Sci. 2007, 1113(1):217-237.
104. Grundtman C., Kreutmayer S.B., Almanzar G., Wick M.C., Wick G. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31(5):960-968.
105. Berberian P.A., Myers W., Tytell M., Challa V., Bond M. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am. J. Pathol. 1990, 136(1):71.
106. Kogure K., Kato H. Altered gene expression in cerebral ischemia. Stroke 1993, 24(12):2121-2127.
107. Shringarpure R., Grune T., Mehlhase J., Davies K.J. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem. 2003, 278(1):311-318.
108. Locke M., Tanguay R.M. Diminished heat shock response in the aged myocardium. Cell Stress Chaperones 1996, 1(4):251.
109. Fenton R.A., Dickson E.W., Meyer T.E., Dobson J.G. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 2000, 32(7):1371-1375.
110. Lamb D.J., Ferns G. The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis. Atherosclerosis 2002, 165(2):231.
111. Morimoto R.I. Cells in stress: transcriptional activation of heat shock genes. Science 1993, 259:1409.
112. Donnahoo K.K., Shames B.D., Harken A.H., Meldrum D.R. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J. Urol. 1999, 162(1):196-203.
113. Satyal S.H., Chen D., Fox S.G., Kramer J.M., Morimoto R.I. Negative regulation of the heat shock transcriptional response by HSBP1. Genes Dev. 1998, 12(13):1962-1974.
114. Ebrahimi M., Kazemi-Bajestani S., Ghayour-Mobarhan M., Ferns G. The status of coronary artery disease and its risk factors in Iran: a review. Iran. Red Crescent Med. J. 2011, 13:615-626.
115. Lancaster G.I., Febbraio M.A. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J. Biol. Chem. 2005, 280(24):23349-23355.
116. Gupta S., Knowlton A.A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am. J. Physiol. Heart Circ. Physiol. 2007, 292(6):H3052-H3056.
117. Rayner K., Chen Y.-X., McNulty M., Simard T., Zhao X., Wells D.J., et al. Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ. Res. 2008, 103(2):133-141.
118. Heltai K., Kis Z., Burian K., Endresz V., Veres A., Ludwig E., et al. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease. Atherosclerosis 2004, 173(2):337-344.
119. Huittinen T., Leinonen M., Tenkanen L., Mänttäri M., Virkkunen H., Pitkänen T., et al. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler. Thromb. Vasc. Biol. 2002, 22(3):431-437.
120. Pockley A.G. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002, 105(8):1012-1017.
121. Xu Q., Dietrich H., Steiner H.J., Gown A.M., Schoel B., Mikuz G., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 1992, 12(7):789-799.
122. George J., Shoenfeld Y., Afek A., Gilburd B., Keren P., Shaish A., et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler. Thromb. Vasc. Biol. 1999, 19(3):505-510.
123. Afek A., George J., Gilburd B., Rauova L., Goldberg I., Kopolovic J., et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J. Autoimmun. 2000, 14(2):115-121.
124. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease?. Immunol. Today 1995, 16(1):27-33.
125. Lindsberg P.J., Grau A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34(10):2518-2532.
126. Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q., et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999, 99(12):1560-1566.
127. Xu Q., Luef G., Weimann S., Gupta R., Wolf H., Wick G. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler. Thromb. Vasc. Biol. 1993, 13(12):1763-1769.
128. Kaufmann S.H. Heat shock proteins and the immune response. Immunol. Today 1990, 11:129-136.
129. Lamb J., Bal V., Mendez-Samperio P., Mehiert A., So A., Rothbard J., et al. Stress proteins may provide a link between the immune response to infection and autoimmunity. Int. Immunol. 1989, 1(2):191-196.
130. Res P.M., Breedveld F., Van Embden J.A., Schaar C., Van Eden W., Cohen I., et al. Synovial fluid T cell reactivity against 65kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988, 332(8609):478-480.
131. Gaston J., Life P.F., Jenner P.J., Colston M., Bacon P.A. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J. Exp. Med. 1990, 171(3):831-841.
132. Wucherpfennig K.W., Newcombe J., Li H., Keddy C., Cuzner M.L., Hafler D.A. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc. Natl. Acad. Sci. USA 1992, 89(10):4588-4592.
133. Georgopoulos C., McFarland H. Heat shock proteins in multiple sclerosis and other autoimmune diseases. Immunol. Today 1993, 14(8):373-375.
134. Child D., Smith C., Williams C. Heat shock protein and the double insult theory for the development of insulin dependent diabetes. J. R. Soc. Med. 1993, 86(4):217.
135. Tun R., Smith M., Lo S., Rook G., Lydyard P., Leslie R. Antibodies to heat shock protein 65kD in type 1 diabetes mellitus. Diabet. Med. 1994, 11(1):66-70.
136. Leishman S.J., Ford P.J., Do H.L., Palmer J.E., Heng N.C.K., West M.J., et al. Periodontal pathogen load and increased antibody response to heat shock protein 60 in patients with cardiovascular disease. J. Clin. Periodontol. 2012, 3:923-930.
137. Van Roon J., Van Eden W., Van Roy J., Lafeber F., Bijlsma J. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J. Clin. Investig. 1997, 100(2):459.
138. Anderton S.M., Van der Zee R., Prakken B., Noordzij A., Van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J. Exp. Med. 1995, 181(3):943-952.
139. Pasceri V., Yeh E.T. A tale of two diseases atherosclerosis and rheumatoid arthritis. Circulation 1999, 100(21):2124-2126.
140. Hightower L.E., Guidon P.T. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble glia-axon transfer proteins. J. Cell. Physiol. 1989, 138(2):257-266.
141. House S., Guidon P., Perdrizet G., Rewinski M., Kyriakos R., Bockman R., et al. Effects of heat shock, stannous chloride, and gallium nitrate on the rat inflammatory response. Cell Stress Chaperones 2001, 6(2):164.
142. Marber M.S., Mestril R., Chi S.-H., Sayen M., Yellon D., Dillmann W. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J. Clin. Investig. 1995, 95(4):1446.
143. Kirby L.B., Mondy J., Brophy C.M. Balloon angioplasty induces heat shock protein 70 in human blood vessels. Ann. Vasc. Surg. 1999, 13(5):475-479.
144. George J., Afek A., Gilburd B., Shoenfeld Y., Harats D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 2001, 38(3):900-905.
145. Lamb D.J., Eales L.-J., Ferns G.A. Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 1999, 143(1):105-113.
146. Ghayour-Mobarhan M., Lamb D.J., Tavallaie S., Ferns G.A.A. Relationship between plasma cholesterol, von Willebrand factor concentrations, extent of atherosclerosis and antibody titres to heat shock proteins-60, -65 and-70 in cholesterol-fed rabbits. Int. J. Exp. Pathol. 2007, 88(4):249-255.
147. Zhang X., Wang X., Zhu H., Kranias E.G., Tang Y., Peng T., et al. Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2. PLoS One 2012, 7(3):e32765.
148. Niwa M., Kozawa O., Matsuno H., Kato K., Uematsu T. Small molecular weight heat shock-related protein, HSP20, exhibits an anti-plate activity by inhibiting receptor-mediated calcium influx. Life Sci. 1999, 66(1):PL7-PL12.
149. Christians E.S., Ishiwata T., Benjamin I.J. Small heat shock proteins in redox metabolism: implications for cardiovascular diseases. Int. J. Biochem. Cell Biol. 2012, 3:1632-1645.
150. Wright B.H., Corton J.M., El-Nahas A.M., Wood R.F., Pockley A.G. Elevated levels of circulating heat shock protein 70 (Hsp70) in peripheral and renal vascular disease. Heart Vessels 2000, 15(1):18-22.
151. Wysocki J., Karawajczyk B., Górski J., Korzeniowski A., Maćkiewicz Z., Kupryszewski G., et al. Human heat shock protein 60 (409-424) fragment is recognized by serum antibodies of patients with acute coronary syndromes. Cardiovasc. Pathol. 2002, 11(4):238-243.
152. Novo G., Cappello F., Rizzo M., Fazio G., Zambuto S., Tortorici E., et al. Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl. Res. 2011, 157(5):285-292.
153. Fan G.-C., Kranias E.G. Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure. J. Mol. Cell. Cardiol. 2011, 51(4):574-577.
154. Fan G.-C., Ren X., Qian J., Yuan Q., Nicolaou P., Wang Y., et al. Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 2005, 111(14):1792-1799.
155. Fan G.-C., Chu G., Mitton B., Song Q., Yuan Q., Kranias E.G. Small heat-shock protein Hsp20 phosphorylation inhibits β-agonist-induced cardiac apoptosis. Circ. Res. 2004, 94(11):1474-1482.
156. Dybdahl B., Wahba A., Lien E., Flo T.H., Waage A., Qureshi N., et al. Inflammatory response after open heart surgery release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 2002, 105(6):685-690.
157. Zhu J., Quyyumi A.A., Wu H., Csako G., Rott D., Zalles-Ganley A., et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2003, 23(6):1055-1059.
158. Johnson A.D., Berberian P.A., Tytell M., Bond M. Atherosclerosis alters the localization of HSP70 in human and macaque aortas. Exp. Mol. Pathol. 1993, 58(3):155-168.
159. Genth-Zotz S., Bolger A.P., Kalra P.R., von Haehling S., Doehner W., Coats A.J.S., et al. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int. J. Cardiol. 2004, 96(3):397-401.
160. Ciocca D.R., Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10(2):86.
161. Yamboliev I.A., Hedges J.C., Mutnick J.L.-M., Adam L.P., Gerthoffer W.T. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am. J. Physiol. Heart Circ. Physiol. 2000, 278(6):H1899-H1907.
162. Ferns G., Shams S., Shafi S. Heat shock protein 27: its potential role in vascular disease. Int. J. Exp. Pathol. 2006, 87(4):253-274.
163. Martin J.L., Mestril R., Hilal-Dandan R., Brunton L.L., Dillmann W.H. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 1997, 96(12):4343-4348.
164. Vander Heide R.S. Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2002, 282(3):H935-H941.
165. Kohn G., Wong H.R., Bshesh K., Zhao B., Vasi N., Denenberg A., et al. Heat shock inhibits tnf-induced ICAM-1 expression in human endothelial cells via I kappa kinase inhibition. Shock 2002, 17(2):91-97.
166. Ghayour-Mobarhan M., Sahebkar A., Parizadeh S.M., Moohebati M., Tavallaie S., Rezakazemi-Bajestani S.M., et al. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int. J. Exp. Pathol. 2008, 89(3):209-215. Epub 2008/05/08.
167. Pourghadamyari H., Moohebati M., Parizadeh S.M.R., Falsoleiman H., Dehghani M., Fazlinezhad A., et al. Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease. Cell Stress Chaperones 2011, 16(3):309-316.
168. Peng E.W., McCaig D., Pollock J., MacArthur K., Lyall F., Danton M.H. Myocardial expression of heat shock protein 70i protects early postoperative right ventricular function in cyanotic tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 2011, 141(5):1184-1191.
169. Park H.K., Park E.-C., Bae S.W., Park M.Y., Kim S.W., Yoo H.S., et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114(9):886-893.
170. Buzzard K.A., Giaccia A.J., Killender M., Anderson R.L. Heat shock protein 72 modulates pathways of stress-induced apoptosis. J. Biol. Chem. 1998, 273(27):17147-17153.
171. Garrido C., Gurbuxani S., Ravagnan L., Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 2001, 286(3):433-442.
172. Feige U., Van Eden W. Infection, Autoimmunity and Autoimmune Disease. Stress-Inducible Cellular Responses 1995, 359-373. Springer, Switzerland.
173. Prohászka Z., Duba J., Horvath L., Csaszar A., Karadi I., Szebeni A., et al. Comparative study on antibodies to human and bacterial 60kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur. J. Clin. Invest. 2001, 31(4):285-292.
174. Cohen I.R., Young D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 1991, 12(4):105-110. Epub 1991/04/01.
175. Machalinska A., Kawa M.P., Marlicz W., Machalinski B. Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis. Acta Ophthalmol. 2012, 90(8):695-703. Epub 2011/11/10.
176. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340(2):115-126. Epub 1999/01/14.
177. Brundel B.J., Henning R.H., Ke L., Van Gelder I.C., Crijns H.J., Kampinga H.H. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation. J. Mol. Cell. Cardiol. 2006, 41(3):555-562. Epub 2006/08/01.
178. Zhu J., Katz R.J., Quyyumi A.A., Canos D.A., Rott D., Csako G., et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation 2004, 109(1):36-41. Epub 2003/12/10.
179. Mukherjee M., De Benedictis C., Jewitt D., Kakkar V.V. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis. Thromb. Haemost. 1996, 75(2):258-260. Epub 1996/02/01.
180. Ibitayo A.I., Sladick J., Tuteja S., Louis-Jacques O., Yamada H., Groblewski G., et al. HSP27 in signal transduction and association with contractile proteins in smooth muscle cells. Am. J. Physiol. Gastrointest. Liver Physiol. 1999, 277(2):G445-G454.
181. Gisolfi C., Matthes R., Kregel K., Oppliger R. Splanchnic sympathetic nerve activity and circulating catecholamines in the hyperthermic rat. J. Appl. Physiol. 1991, 70(4):1821-1826.
182. Hobbesland Å., Kjuus H., Thelle D.S. Mortality from cardiovascular diseases and sudden death in ferroalloy plants. Scand. J. Work Environ. Health 1997, 1997:334-341.
183. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000, 102(1):14-20.
184. Shin Y.-O., Bae J.-S., Lee J.-B., Kim J.-K., Kim Y.-J., Kim C., et al. Effect of cardiac rehabilitation and statin treatment on anti-HSP antibody titers in patients with coronary artery disease after percutaneous coronary intervention. Int. Heart J. 2006, 47(5):671-682.
185. Belli F., Testori A., Rivoltini L., Maio M., Andreola G., Sertoli M.R., et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J. Clin. Oncol. 2002, 20(20):4169-4180.
186. Lamb D.J., El-Sankary W., Ferns G. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 2003, 167(2):177.
187. Xu Q., Wick G., Willeit J., Marosi M., Kiechl S., Luef G., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993, 341(8840):255-259.
188. Frostegård J., Lemne C., Andersson B., Van der Zee R., Kiessling R., de Faire U. Association of serum antibodies to heat-shock protein 65 with borderline hypertension. Hypertension 1997, 29(1):40-44.
189. Mazzaferro V., Coppa J., Carrabba M.G., Rivoltini L., Schiavo M., Regalia E., et al. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin. Cancer Res. 2003, 9(9):3235-3245.
190. Schett G., Xu Q., Amberger A., Van der Zee R., Recheis H., Willeit J., et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Investig. 1995, 96(6):2569.
191. Arata S., Hamaguchi S., Nose K. Effects of the overexpression of the small heat shock protein, HSP27, on the sensitivity of human fibroblast cells exposed to oxidative stress. J. Cell. Physiol. 2005, 163(3):458-465.
192. Arata S., Hamaguchi S., Nose K. Inhibition of colony formation of NIH 3T3 cells by the expression of the small molecular weight heat shock protein HSP27: involvement of its phosphorylation and aggregation at the C-terminal region. J. Cell. Physiol. 1997, 170(1):19-26.
193. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112(4):453-465.
194. Elkind M.S. Inflammatory mechanisms of stroke. Stroke 2010, 41(10 Suppl. 1):S3-S8.
195. Kowalski M., Konturek P., Pieniazek P., Karczewska E., Kluczka A., Grove R., et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication an coronary lumen reduction after percutations coronary angioplasty. Dig. Liver Dis. 2001, 33(3):222-229.
196. Banecka-Majkutewicz Z., Sawuła W., Kadziński L., Wegrzyn A., Banecki B. Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke-pathogenic and therapeutic implications. Acta Biochim. Pol. 2012, 3:495-499.
197. Borges J.C., Ramos C.H. Characterization of nucleotide-induced changes on the quaternary structure of human 70kDa heat shock protein Hsp70. 1 by analytical ultracentrifugation. BMB Rep. 2009, 42(3):166-171.
198. Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen K.S., Equils O., et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 2002, 168(3):1435-1440.
199. Burut D.F.P., Borai A., Livingstone C., Ferns G. Serum heat shock protein 27 antigen and antibody levels appear to be related to the macrovascular complications associated with insulin resistance: a pilot study. Cell Stress Chaperones 2010, 15(4):379-386.
200. Bruey J.-M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat. Cell Biol. 2000, 2(9):645-652.
201. Danan I.J., Rashed E.R., Depre C. Therapeutic potential of H11 kinase for the ischemic heart. Cardiovasc. Drug Rev. 2007, 25(1):14-29.
202. Figueredo A., Ibarra J., Rodriguez A., Molino A., la Concha E., Fernandez-Cruz A., et al. Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: their relationship with vascular complications. Clin. Immunol. Immunopathol. 1996, 79(3):252-255.
203. Pockley A.G., de Faire U., Kiessling R., Lemne C., Thulin T., Frostegård J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J. Hypertens. 2002, 20(9):1815-1820.
204. Tanonaka K., Yoshida H., Toga W., Furuhama K.-i., Takeo S. Myocardial heat shock proteins during the development of heart failure. Biochem. Biophys. Res. Commun. 2001, 283(2):520-525.
205. Kruger A., Petersen S., Turkseven S. Hyperlipidaemia and cardiovascular disease. Circ. Res. 2005, 97:524-532.
206. Kervinen H., Huittinen T., Vaarala O., Leinonen M., Saikku P., Manninen V., et al. Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk. Atherosclerosis 2003, 169(2):339-344.
207. Kee H.J., Eom G.H., Joung H., Shin S., Kim J.-R., Cho Y.K., et al. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy. Circ. Res. 2008, 103(11):1259-1269.
208. Kumarapeli A.R., Su H., Huang W., Tang M., Zheng H., Horak K.M., et al. αB-Crystallin suppresses pressure overload cardiac hypertrophy. Circ. Res. 2008, 103(12):1473-1482.
209. Vondriska T.M., Wang Y. A new (heat) shocking player in cardiac hypertrophy. Circ. Res. 2008, 103(11):1194-1196.
210. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002, 110(4):479-488.
211. Nishizawa J., Nakai A., Matsuda K., Komeda M., Ban T., Nagata K. Reactive oxygen species play an important role in the activation of heat shock factor 1 in ischemic-reperfused heart. Circulation 1999, 99(7):934-941.
212. Depre C., Tomlinson J.E., Kudej R.K., Gaussin V., Thompson E., Kim S.-J., et al. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(16):9336-9341.
213. Qian J., Ren X., Wang X., Zhang P., Jones W.K., Molkentin J.D., et al. Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death. Circ. Res. 2009, 105(12):1223-1231.
214. Wang Y., Chen L., Hagiwara N., Knowlton A. Regulation of heat shock protein 60 and 72 expression in the failing heart. J. Mol. Cell. Cardiol. 2010, 48(2):360-366.
215. Imanshahidi M., Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008, 22(8):999-1012.
216. Pockley A.G., Bulmer J., Hanks B.M., Wright B.H. Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 1999, 4(1):29.
217. Sidorik L., Kyyamova R., Bobyk V., Kapustian L., Rozhko O., Vigontina O., et al. Molecular chaperone, HSP60, and cytochrome P450 2E1 co-expression in dilated cardiomyopathy. Cell Biol. Int. 2005, 29(1):51-55.
218. Lin L., Kim S.-C., Wang Y., Gupta S., Davis B., Simon S.I., et al. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2007, 293(4):H2238-H2247.
219. Henderson B. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem. Funct. 2010, 28(1):1-14.
220. Niizeki T., Takeishi Y., Watanabe T., Nitobe J., Miyashita T., Miyamoto T., et al. Relation of serum heat shock protein 60 level to severity and prognosis in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 2008, 102(5):606-610.
221. Miller H., Poon S., Hibbert B., Rayner K., Chen Y.-X., O'Brien E.R. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor β mechanistic insight into the vascular effects of estrogens. Arterioscler. Thromb. Vasc. Biol. 2005, 25(3):e10-e14.
222. Bruening W., Roy J., Giasson B., Figlewicz D.A., Mushynski W.E., Durham H.D. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 1999, 72(2):693-699.
223. Garrido C., Bruey J.-M., Fromentin A., Hammann A., Arrigo A.P., Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 1999, 13(14):2061-2070.
224. Ramanathan R.K., Egorin M.J., Erlichman C., Remick S.C., Ramalingam S.S., Naret C., et al. Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors. J. Clin. Oncol. 2010, 28(9):1520-1526.
225. Ritossa F. Discovery of the heat shock response. Cell Stress Chaperones 1996, 1(2):97.
226. Xu Q., Kleindienst R., Schett G., Waitz W., Jindal S., Gupta R.S., et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 1996, 123(1):145-155.
227. Dillmann W.H. Small heat shock proteins and protection against injury. Ann. N. Y. Acad. Sci. 1999, 874(1):66-68.
228. Brundel B.J., Ke L., Dijkhuis A.-J., Qi X., Shiroshita-Takeshita A., Nattel S., et al. Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc. Res. 2008, 78(3):422-428.
229. Toubi E., Shoenfeld Y. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?. Lupus 2005, 14(9):665-669.
230. Ooie T., Takahashi N., Saikawa T., Nawata T., Arikawa M., Yamanaka K., et al. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 2001, 104(15):1837-1843.
231. Kieran D., Kalmar B., Dick J.R., Riddoch-Contreras J., Burnstock G., Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 2004, 10(4):402-405.
232. Allison A.C., Cacabelos R., Lombardi V.R., Álvarez X.A., Vigo C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25(7):1341-1357.
233. Wang X., Tokuda H., Hatakeyama D., Hirade K., Niwa M., Ito H., et al. Mechanism of simvastatin on induction of heat shock protein in osteoblasts. Arch. Biochem. Biophys. 2003, 415(1):6-13.
234. Hirsch A.T. Vascular disease, hypertension, and prevention: "from endothelium to clinical events". J. Am. Coll. Cardiol. 2003, 42(2):377-379.
235. Okada T., Ayada K., Usui S., Yokota K., Cui J., Kawahara Y., et al. Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease. J. Autoimmun. 2007, 29(2):106-115.
236. Hoppichler F., Koch T., Dzien A., Gschwandtner G., Lechleitner M. Prognostic value of antibody titre to heat-shock protein 65 on cardiovascular events. Cardiology 2001, 94(4):220-223.
237. Gromadzka G., Zielińska J., Ryglewicz D., Fiszer U., Członkowska A. Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia. Cerebrovasc. Dis. 2001, 12(3):235-239.
238. Jin X., Xiao C., Tanguay R.M., Yang L., Wang F., Chen M., et al. Correlation of lymphocyte heat shock protein 70 levels with neurologic deficits in elderly patients with cerebral infarction. Am. J. Med. 2004, 117(6):406-411.
239. Mehta T., Greenman J., Ettelaie C., Venkatasubramaniam A., Chetter I., McCollum P. Heat shock proteins in vascular disease-a review. Eur. J. Vasc. Endovasc. Surg. 2005, 29(4):395-402.
240. Hoos A., Levey D.L. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications. Expert Rev. Vaccines 2003, 2(3):369-379.
241. Sander B., Skansen-Saphir U., Damm O., Håkansson L., Andersson J., Andersson U. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guerin. Immunology 1995, 86(4):512.
242. Stary H. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989, 9(1 Suppl.):I19.
243. Sahebkar A., Mohammadi A., Atabati A., Rahiman S., Tavallaie S., Iranshahi M., et al. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother. Res. 2013, 27(12):1883-1888. Epub 2013/03/16.